Deployment
da Vinci (and Ion) at United States
Intuitive Surgical (NASDAQ: ISRG; founded 1995, Sunnyvale, California) is the dominant incumbent and verified gold standard of surgical robotics. Its da Vinci platform spans the multi-port X and Xi systems, the SP single-port system, and the fifth-generation da Vinci 5, which the FDA cleared via 510(k) on March 14, 2024 with a headline Force Feedback sensing feature, alongside the Ion endoluminal robotic bronchoscopy system cleared in February 2019. As of its SEC Form 10-Q for the quarter ended March 31, 2026, the verified installed base was 11,395 da Vinci systems, up 12 percent year over year and including 1,464 da Vinci 5 units, plus 1,041 Ion systems, up 22 percent, with worldwide procedures growing about 17 percent. Surgical robotics sits in the registry as a deliberate axis-extension: physical AI operating in the medical regulatory regime, where FDA clearance is the verified gating event for maturity, and Intuitive clears it across multiple platforms and generations, placing it at production maturity. On AI substance, da Vinci is a master-slave teleoperated system with shipped analytics-grade AI such as Case Insights and machine-vision interface features, and Force Feedback is a shipped sensing feature rather than autonomy; autonomous suturing and tissue manipulation via vision-language models are research demonstrations on da Vinci hardware, not shipped features, and the 4,000-mile telesurgery demonstration is investigational. The widely cited 43-percent-less-force figure is preclinical and marketing-sourced rather than an outcomes-verified clinical result.
da Vinci (and Ion) by Intuitive Surgical · Operated by Intuitive Surgical · Unverified
Machine-readable surfaces
- Markdown mirror: /deployments/intuitive-da-vinci-5-tampa-general.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/robots/35d0810e-e670-4293-873b-3e36c6730b80
- Data documentation: /data
- Query this programmatically: Deploy MCP
Tampa General Hospital announced acquisition of the Intuitive Surgical da Vinci 5 robotic surgical system in August 2024, among the early adopters during the system's limited commercial launch.
Key facts
- Announced
- August 2024
- System
- da Vinci 5 (5th-gen multiport)
- Partner
- Tampa General Hospital
- Status
- Early adopter during limited commercial launch
Exposure
- Customer segment
- healthcare
- Scale tier
- pilot lt10
- Customer
- Tampa General Hospital
Each exposure value carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Safety record
No incidents on record for da Vinci (and Ion) at United States.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
- Trust tier
- Unverified
- Last updated
- 2026-06-28
- Model
- da Vinci (and Ion)
- Company
- Intuitive Surgical
- Location
- United States
- Operator
- Intuitive Surgical
- Status
- operational
- First seen
- 2024-08-01
- ID
35d0810e-e670-4293-873b-3e36c6730b80
Sources (1)
Methodology: Unreviewed · 1 source (no primary) · last reviewed 2026-06-28
Verification posture
Unreviewed
Low confidence
Review state
Stable
Last reviewed 2026-06-28
Maturity + lifecycle
Maturity stage: production
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for da Vinci (and Ion) at United States.Common questions
- What is the da Vinci (and Ion) deployment at United States?
- da Vinci (and Ion), built by Intuitive Surgical, is recorded as a deployment at United States on the DEPLOY registry. Intuitive Surgical operates the deployment directly.
- Who operates da Vinci (and Ion) at United States?
- Intuitive Surgical, the manufacturer of da Vinci (and Ion), operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
- When did the da Vinci (and Ion) deployment at United States go live?
- The deployment is recorded as starting August 1, 2024 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
- Have there been incidents at the da Vinci (and Ion) deployment at United States?
- No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.
- Is da Vinci (and Ion) at United States safe?
- da Vinci (and Ion) at United States has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Deploy Watch
Track this deployment.
We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.